WO2003086305A8 - Biodegradable peg-based polymer formulations in ocular applications - Google Patents

Biodegradable peg-based polymer formulations in ocular applications

Info

Publication number
WO2003086305A8
WO2003086305A8 PCT/US2003/011061 US0311061W WO03086305A8 WO 2003086305 A8 WO2003086305 A8 WO 2003086305A8 US 0311061 W US0311061 W US 0311061W WO 03086305 A8 WO03086305 A8 WO 03086305A8
Authority
WO
WIPO (PCT)
Prior art keywords
eye
based polymer
polymer formulations
ocular applications
biodegradable peg
Prior art date
Application number
PCT/US2003/011061
Other languages
French (fr)
Other versions
WO2003086305A2 (en
WO2003086305A3 (en
Inventor
Daniel M Schwartz
Keith Duncan
Jay Stewart
Original Assignee
Univ California
Daniel M Schwartz
Keith Duncan
Jay Stewart
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California, Daniel M Schwartz, Keith Duncan, Jay Stewart filed Critical Univ California
Priority to AU2003226059A priority Critical patent/AU2003226059A1/en
Publication of WO2003086305A2 publication Critical patent/WO2003086305A2/en
Publication of WO2003086305A8 publication Critical patent/WO2003086305A8/en
Publication of WO2003086305A3 publication Critical patent/WO2003086305A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/046—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Abstract

The present invention relates to methods and pharmaceutical compositions involving the use of bioerodible (biodegradable) polymers to address fundamental needs in ocular surgery including sealants and sealing methods, barriers to cellular adhesion and proliferation, and mechanical barriers. In a particular embodiment, the present invention is also directed to the treatment of intraocular hypotony in an eye by limiting the flow of aqueous from the eye. In a preferred embodiment, application of a polymer, such as to the angle of the eye, limits the flow, thereby increasing the intraocular pressure.
PCT/US2003/011061 2002-04-10 2003-04-10 Biodegradable peg-based polymer formulations in ocular applications WO2003086305A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003226059A AU2003226059A1 (en) 2002-04-10 2003-04-10 Biodegradable peg-based polymer formulations in ocular applications

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37153102P 2002-04-10 2002-04-10
US60/371,531 2002-04-10

Publications (3)

Publication Number Publication Date
WO2003086305A2 WO2003086305A2 (en) 2003-10-23
WO2003086305A8 true WO2003086305A8 (en) 2004-02-12
WO2003086305A3 WO2003086305A3 (en) 2004-03-18

Family

ID=29250696

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/011061 WO2003086305A2 (en) 2002-04-10 2003-04-10 Biodegradable peg-based polymer formulations in ocular applications

Country Status (3)

Country Link
US (1) US20030223957A1 (en)
AU (1) AU2003226059A1 (en)
WO (1) WO2003086305A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8288362B2 (en) * 2004-05-07 2012-10-16 S.K. Pharmaceuticals, Inc. Stabilized glycosaminoglycan preparations and related methods
US7727544B2 (en) * 2004-05-07 2010-06-01 The Regents Of The University Of California Treatment of myopia
WO2005115489A2 (en) * 2004-05-24 2005-12-08 Genzyme Corporation Adherent polymeric compositions
CA2635374C (en) 2006-01-11 2015-12-08 Hyperbranch Medical Technology, Inc. Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices
EP1864777B1 (en) * 2006-06-08 2009-09-23 DWI an der RWTH Aachen e.V. Structuring hydrogels
JP2010534515A (en) * 2007-07-23 2010-11-11 ハイパーブランチ メディカル テクノロジー， インコーポレイテッド Polymerization masking material for covering wound sites and methods of use thereof
US20090131303A1 (en) * 2007-11-16 2009-05-21 Bor-Shyue Hong Methods and compositions for treating dry eye
US9877973B2 (en) * 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
WO2011017123A2 (en) 2009-07-27 2011-02-10 Endologix, Inc. Stent graft
US10189773B2 (en) 2010-05-07 2019-01-29 Medicus Biosciences, Llc In-vivo gelling pharmaceutical pre-formulation
US10111985B2 (en) 2011-08-10 2018-10-30 Medicus Biosciences, Llc Biocompatible hydrogel polymer formulations for the controlled delivery of biomolecules
US11083821B2 (en) 2011-08-10 2021-08-10 C.P. Medical Corporation Biocompatible hydrogel polymer formulations for the controlled delivery of biomolecules
RU2485919C1 (en) * 2012-04-12 2013-06-27 Федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения и социального развития Российской Федерации Method of medicinal application of cornea with bioplastic material "hyamatrix"
EP2846847B1 (en) 2012-05-11 2020-03-25 C.P. Medical Corporation Biocompatible hydrogel treatments for retinal detachment
JP2016501931A (en) 2012-11-21 2016-01-21 ユニバーシティー オブ ルイヴィル リサーチ ファウンデーション，インコーポレーテッドＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｌｏｕｉｓｖｉｌｌｅ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ，Ｉｎｃ． Compositions and methods for reducing oxidative damage
KR102198622B1 (en) * 2013-03-14 2021-01-05 유니버시티 오브 매사추세츠 Methods of inhibiting cataracts and presbyopia
EP2968680B1 (en) 2013-03-14 2023-05-03 C.P. Medical Corporation Solid polyglycol-based biocompatible pre-formulation
WO2015102000A2 (en) * 2014-01-02 2015-07-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Ophthalmic viscosurgical device
EP3256136A4 (en) 2015-02-09 2018-11-21 University Of Louisville Research Foundation, Inc. Ophthalmic compositions and methods for reducing oxidative damage to an eye lens
US10980882B2 (en) * 2015-09-25 2021-04-20 Jennifer J. KANG-MIELER Biodegradable microsphere-hydrogel ocular drug delivery system
US11266608B2 (en) 2015-09-25 2022-03-08 Jennifer J. Kang-Mteler Biodegradable extended release microsphere-hydrogel ocular drug delivery system and method
SG11201803606XA (en) 2015-11-13 2018-05-30 Univ Massachusetts Bifunctional molecules containing peg for use in inhibiting cataracts and presbyopia
US11752099B2 (en) * 2017-03-27 2023-09-12 W. L. Gore & Associates, Inc. Injectable and biodegradable polymer formulations for controlled release of bioactive agents
WO2021026214A1 (en) * 2019-08-06 2021-02-11 Dose Medical Corporation Bioerodible cross-linked hydrogel implants and related methods of use
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
JPWO2022092209A1 (en) * 2020-10-29 2022-05-05
WO2022173829A1 (en) * 2021-02-09 2022-08-18 The Brigham And Women's Hospital, Inc. Pectin compositions and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7009034B2 (en) * 1996-09-23 2006-03-07 Incept, Llc Biocompatible crosslinked polymers
US6566406B1 (en) * 1998-12-04 2003-05-20 Incept, Llc Biocompatible crosslinked polymers
CA2305349A1 (en) * 1997-10-27 1999-05-06 Alexander R. Irvine Methods and pharmaceutical compositions for the closure of retinal breaks

Also Published As

Publication number Publication date
WO2003086305A2 (en) 2003-10-23
AU2003226059A8 (en) 2003-10-27
US20030223957A1 (en) 2003-12-04
AU2003226059A1 (en) 2003-10-27
WO2003086305A3 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
WO2003086305A3 (en) Biodegradable peg-based polymer formulations in ocular applications
DE60331367D1 (en) ACTIVE COMPOSITION OF FAST GELING POLYMERIC COMPOSITION
WO2010147864A3 (en) Biomedical devices, polymeric materials and contact lenses comprising the same
TNSN08079A1 (en) Pharmaceutical compositions for the treatment of inner ear disorders
BRPI0711620A2 (en) polymeric mixtures of anionic and cationic polysaccharides and use of these
CY1114048T1 (en) Combination of brimonidine and timolol for topical ophthalmic use
CA2522232A1 (en) Cross-linked polysaccharide composition
WO2005002520A3 (en) Ophthalmic compositions for treating ocular hypertension
CA2453592A1 (en) Dry hemostatic compositions and methods for their preparation
WO2005055924A3 (en) Skin adherent hydrogels
DE60135784D1 (en) THE VISCOSITY OF POLYALKYLENE GLYCOL INCREASING POLYMERS FORMULATIONS
WO2008073909A3 (en) Use of peo-pbo block copolymers in ophthalmic compositions
WO2007081396A3 (en) Initiators and crosslinkable polymeric materials
WO2005051316A3 (en) Polymer compositions and methods for their use
WO2007010034A3 (en) Ampholytic copolymer, production thereof, and use of the same
WO2006005058A3 (en) Polymer-factor ix moiety conjugates
WO2001049240A3 (en) Hydrogels
WO2004009664A3 (en) Biodegradable triblock copolymers, synthesis methods therefor, and hydrogels and biomaterials made there from
WO2004075923A3 (en) Polymer-factor viii moiety conjugates
WO2003000777A3 (en) Multi-arm block copolymers as drug delivery vehicles
WO2009064977A3 (en) Dextran-based polymer tissue adhesive for medical use
DE602006019392D1 (en) ADHESIVES, PREPARATION AND APPLICATIONS THEREOF
DE60315322D1 (en) COMPOSITIONS WITH IMPROVED ANTIMICROBIAL EFFICACY AGAINST ACANTHAMOEBAE
TW200515919A (en) Bioerodible sustained release drug delivery systems
WO2003059382A3 (en) Pharmaceutical compositions comprising polyanionic polymers and amphiphilic block copolymers and methods of use thereof to improve gene expression

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 43/2003 UNDER (72, 75) ADD "SCHWARTZ, DANIEL, M. [US/US]; 42 CALHOUN TERRACE, SAN FRANCISCO, CA 94133 (US)."

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP